drugset / Trial / NCT00568984
Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia. The aim of this trial is to investigate the efficacy of blood glucose control with combination therapy of repaglinide and metformin compared to conventional treatment with a sulphonylurea or metformin in monotherapy in type 2 diabetes
Timeline
- Start
- 2002-11-21
- Primary completion
- 2003-11-10
- Completion
- 2003-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | — | — |
| Subject | Repaglinide | Small molecule | — | — |
| Subject | glicazide | Unknown | — | — |